- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Progressive Castration-resistant Prostate Cancer
Total 1183 results
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Italy, Spain, Belgium, Canada, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Turkey, Australia, Chile, Germany, Japan, Netherlands, Slovakia
-
Taiho Oncology, Inc.Active, not recruitingMetastatic Castration Resistant Prostate CancerFrance, United States, Spain, United Kingdom
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Terminated
-
Peking Union Medical College HospitalCompletedMetastatic Castration-resistant Prostate CancerChina
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
ARTBIO Inc.Completed
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaCompletedMetastatic Castration Resistant Prostate CancerAustralia
-
SpectronRXJanssen Research & Development, LLC; Invicro; Tomopath Inc.TerminatedMetastatic Disease | Castration-Resistant Prostatic CancerUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Puma Biotechnology, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer Metastatic | Metastatic Prostate AdenocarcinomaUnited States
-
Syntrix Biosystems, Inc.National Cancer Institute (NCI)RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
BayerRecruitingMetastatic Castration-resistant Prostate CancerUnited Kingdom, Netherlands, Finland
-
Fusion Pharmaceuticals Inc.RecruitingMetastatic Castration Resistant Prostate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
-
Aragon Pharmaceuticals, Inc.Active, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, United Kingdom
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaActive, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerJapan
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.Active, not recruiting
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Hinova Pharmaceuticals Aus Pty LtdCompletedMetastatic Castration-resistant Prostate CancerAustralia
-
Dana-Farber Cancer InstituteEli Lilly and Company; Genentech, Inc.Active, not recruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Australian and New Zealand Urogenital and Prostate...Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...Active, not recruitingMetastatic Castration-Resistant Prostate CancerAustralia
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailableMetastatic Castration-Resistant Prostate Cancer
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
Université de SherbrookeCanadian Cancer Society (CCS); Fonds de la Recherche en Santé du Québec; Merck... and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerCanada
-
Tceleron Therapeutics, Inc.TerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Duke UniversityMemorial Sloan Kettering Cancer Center; University of Wisconsin, MadisonRecruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer MetastaticUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruitingMetastatic Castration-resistant Prostate Cancer, mCRPCChina
-
Centre Georges Francois LeclercNot yet recruitingPatients With Metastatic Castration-resistant Prostate Cancer
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
BayerRecruitingNon-metastatic Castration-resistant Prostate CancerIndia
-
British Columbia Cancer AgencyRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)Canada
-
AstraZenecaCompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Advanced Accelerator ApplicationsNo longer availableMetastatic Castration-resistant Prostate Cancer (mCRPC)
-
University of California, San FranciscoNational Cancer Institute (NCI); Prostate Cancer FoundationActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer | Castration Levels of Testosterone | Stage IVA Prostate Cancer | Stage IVB Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)CompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of TestosteroneUnited States
-
SL VAXiGENRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)Korea, Republic of
-
Yantai LNC Biotechnology Singapore PTE. LTD.Not yet recruitingMetastatic Castration-resistant Prostate Cancer, mCRPC
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
University of OklahomaDendreonRecruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)Australia
-
BayerActive, not recruitingNon-metastatic Castration-resistant Prostate CancerUnited States
-
BayerActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States, United Kingdom, Finland
-
BayerCompletedNon-metastatic Castration-resistant Prostate CancerUnited States
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerChina
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
Fred Hutchinson Cancer CenterPromiCell Therapeutics, Inc.Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)RecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States
-
University of WashingtonNovartis; Institute for Prostate Cancer Research (IPCR)Not yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate AdenocarcinomaUnited States